Literature DB >> 16713451

Toll-like receptors: applications to dermatologic disease.

Sammy S W Kang1, Lynda S Kauls, Anthony A Gaspari.   

Abstract

UNLABELLED: Toll-like receptors are a recently identified group of receptors that are an important component of the immune system. Thus far, ten different receptors have been identified and have unique tissue distribution, ligand binding properties, cellular signaling pathways, and cytokine production profiles. Importantly, ligand binding has been shown to regulate both the adaptive and host immune response; thus, defects in this pathway have the potential to lead to increased susceptibility to infection and inflammatory dysregulation. In this article, the burgeoning literature pertinent to the discovery and signaling mechanisms are reviewed in addition to the discussion of the important role Toll-like receptors may play in the pathogenesis of numerous skin diseases. LEARNING
OBJECTIVE: At the completion of this learning activity, participants should be familiar with the role of Toll-like receptors in host defenses and their relevance to dermatologic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713451     DOI: 10.1016/j.jaad.2005.05.004

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  21 in total

1.  The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators.

Authors:  Whitney Valins; Sadegh Amini; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

Review 2.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

3.  Sesquiterpene lactone parthenolide attenuates production of inflammatory mediators by suppressing the Toll-like receptor-4-mediated activation of the Akt, mTOR, and NF-κB pathways.

Authors:  Yoon Jeong Nam; Da Hee Lee; Min Sung Lee; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-15       Impact factor: 3.000

4.  Expression of Toll-like Receptor 2 in Cultured Human Keratinocytes: The Effect of Bacterial Antigens, Cytokines and Calcium Concentration.

Authors:  Bark-Lynn Lew; Woo-Young Sim; Nack-In Kim
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 5.  Toll-Like Receptor Pathways in Autoimmune Diseases.

Authors:  Ji-Qing Chen; Peter Szodoray; Margit Zeher
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

6.  Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4.

Authors:  Wesley Lewis; Eva Simanyi; Hui Li; Camilla A Thompson; Tahseen H Nasti; Tarannum Jaleel; Hui Xu; Nabiha Yusuf
Journal:  Arch Biochem Biophys       Date:  2011-01-12       Impact factor: 4.013

7.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

Review 8.  Toll-like receptors in skin infections and inflammatory diseases.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Infect Disord Drug Targets       Date:  2008-09

Review 9.  Antimicrobial peptides, skin infections, and atopic dermatitis.

Authors:  Tissa R Hata; Richard L Gallo
Journal:  Semin Cutan Med Surg       Date:  2008-06

10.  Association of toll-like receptor 2 gene polymorphisms with normal tension glaucoma.

Authors:  Jutaro Nakamura; Akira Meguro; Masao Ota; Eiichi Nomura; Tadayuki Nishide; Kenji Kashiwagi; Fumihiko Mabuchi; Hiroyuki Iijima; Kazuhide Kawase; Tetsuya Yamamoto; Makoto Nakamura; Akira Negi; Takeshi Sagara; Teruo Nishida; Masaru Inatani; Hidenobu Tanihara; Makoto Aihara; Makoto Araie; Takeo Fukuchi; Haruki Abe; Tomomi Higashide; Kazuhisa Sugiyama; Takashi Kanamoto; Yoshiaki Kiuchi; Aiko Iwase; Shigeaki Ohno; Hidetoshi Inoko; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2009-12-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.